Schedule 13G ownership disclosure
Maravai LifeSciences Holdings Inc
Common Stock · CUSIP: 56600D107
Event date: 2025-09-30
- Filing-level shares
- 7,125,498
- Percent of class
- 4.92%
- The Vanguard Group
Shares: 7,125,498 · Class: 4.92%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000251
- Form type
- SCHEDULE 13G/A
- Filer
- MARAVAI LIFESCIENCES HOLDINGS, INC.
- CIK
- CIK 1823239
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership